Why the study?
Despite recent advancements, right heart failure remains associated with substantial morbidity and mortality, while its management is hindered by under-recognition, a lack of standardized definitions, limited randomized controlled trials, and few therapeutic options, creating an urgent need for consensus and guidance.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Our hope is that this framework gives clinicians a structured way to recognize and manage right heart failure earlier, and gives the research community a foundation to close the gaps that have limited progress in this field.”
“Right heart failure has too often been treated as an afterthought of left heart disease. This statement makes the case that RHF should be recognized and managed as its own syndrome, with a diagnostic approach and treatment strategy tailored to right ventricular physiology.”
This Heart Failure Society of America Scientific Statement provides consensus guidance on the recognition, risk stratification, and management of acute and chronic right heart failure, including the expanding roles of temporary mechanical circulatory support and percutaneous tricuspid interventions.
Right heart failure (RHF), both acute and chronic is increasingly recognized as a distinct and clinically significant syndrome across the spectrum of cardiovascular disease. Estimates suggest RHF complicates >25-30% of hospitalizations for acute decompensated HF and is nearly universal in advanced pulmonary hypertension (PH) (1) Despite recent diagnostic and therapeutic advancements, RHF remains associated with substantial morbidity, mortality, and impaired quality of life. Addressing RHF requires dedicated strategies tailored to its pathophysiology, including early identification, risk stratification, and novel therapies. (2) While randomized controlled trials (RCTs) on the topic remain limited, there has been increasing emphasis on early recognition and management of RHF (especially in the setting of left ventricular [LV] failure). In addition, there is an expanding role for temporary mechanical circulatory support (MCS) in acute RHF and percutaneous tricuspid interventions in chronic RHF. Yet, the field remains limited by its under-recognition, lack of standardized definitions, and limited therapeutic options, which underscore the urgent need for consensus and guidance.
No takes yet. Share an insight, caveat, or question.
Kanwar et al. (2026) conducted a review in Right heart failure. Right heart failure complicates >25-30% of acute decompensated heart failure hospitalizations and requires dedicated diagnostic and management strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: